Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alain

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Molecular and Cellular Endocrinology|September 5, 2009
Regulation of vitamin D receptor function in MEN1-related parathyroid adenomasKoen M A Dreijerink, Radhika A Varier, Rick van Nuland, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 geneMaarten P Tabor, Viola M M van Houten, J Alain Kummer, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neckDavid R Colnot, Jan C Roos, Remco de Bree, et al.
BJU International|August 22, 2022
Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trialLeonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
The Journal of Pathology|November 16, 2002
Mutated p53 as a molecular marker for the diagnosis of head and neck cancerViola M M van Houten, Maarten P Tabor, Michiel W M van den Brekel, et al.
European Urology Oncology|June 27, 2019
Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?Leonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
Blood|January 5, 2002
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?Bellinda A Bladergroen, Chris J L M Meijer, Rosita L ten Berge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathwaysAlfons S K de Hooge, Dagmar Berghuis, Susy Justo Santos, et al.
International Journal of Cancer|July 2, 2009
Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcomePieter J A de Koning, Niels Bovenschen, Frank K J Leusink, et al.
Molecular Immunology|May 9, 2007
Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activationMerel C M Strik, Pieter J A de Koning, Monique J Kleijmeer, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Endocrinology|September 5, 2009
Regulation of vitamin D receptor function in MEN1-related parathyroid adenomasKoen M A Dreijerink, Radhika A Varier, Rick van Nuland, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 geneMaarten P Tabor, Viola M M van Houten, J Alain Kummer, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neckDavid R Colnot, Jan C Roos, Remco de Bree, et al.
BJU International|August 22, 2022
Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trialLeonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
The Journal of Pathology|November 16, 2002
Mutated p53 as a molecular marker for the diagnosis of head and neck cancerViola M M van Houten, Maarten P Tabor, Michiel W M van den Brekel, et al.
European Urology Oncology|June 27, 2019
Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?Leonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
Blood|January 5, 2002
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?Bellinda A Bladergroen, Chris J L M Meijer, Rosita L ten Berge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathwaysAlfons S K de Hooge, Dagmar Berghuis, Susy Justo Santos, et al.
International Journal of Cancer|July 2, 2009
Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcomePieter J A de Koning, Niels Bovenschen, Frank K J Leusink, et al.
Molecular Immunology|May 9, 2007
Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activationMerel C M Strik, Pieter J A de Koning, Monique J Kleijmeer, et al.
Pageof 7